Prostate MRI currently lacks the accuracy to replace biopsies in active surveillance for prostate cancer. The negative predictive value of MRI remains below 90%, the general goal for safely avoiding ...

MARKHAM, Ontario--(BUSINESS WIRE)--Exact Imaging today announced results from its OPTIMUM clinical trial demonstrating the non-inferiority of its ExactVu™ micro-ultrasound platform to MRI ...

The ExactVu micro-ultrasound platform is noninferior to MRI in detecting clinically significant prostate cancer in biopsy-naïve men. Microultrasonography offers a cost-effective, in-office alternative ...

The objective of this study is to evaluate whether prior Holmium laser enucleation of the prostate (HoLEP) affects the diagnostic accuracy of multiparametric prostate MRI (mpMRI) with PI-RADS scoring ...

Dr. Aytekin Oto discussed Prostate MRI 101, noting that prostate MRI has evolved significantly since its first publication in 1982, with multiparametric MRI now embraced worldwide. With regards to ...

Biparametric MRI, omitting gadolinium contrast, is noninferior to multiparametric MRI for detecting significant prostate cancer, offering a faster, cheaper alternative. The PRIME trial involved 490 ...

Biparametric MRI, which omits the dynamic contrast enhancement sequence, can detect clinically significant prostate cancer as well as multiparametric MRI. Biparametric MRI performs as well as ...

A quicker, cheaper MRI scan was just as accurate at diagnosing prostate cancer as the current 30-40 minute scan and should be rolled out to make MRI scans more accessible to men who need one, ...

Purpose: This study was intended to evaluate the performance of biparametric MRI (bpMRI) radiomics for detecting clinically significant prostate cancer (csPCa) in men with prostate-specific antigen ...

Abstract: Purpose: Prostate cancer (PCa) risk stratification is of critical importance for clinical diagnosis and treatment planning. Magnetic resonance imaging (MRI) is commonly used for the ...